A survey assessing knowledge and perception of prescribers towards generic medicines in Hospital Seberang Jaya

Abstract

Promoting the use of generic medicine has provided an opportunity for policy makers to make effective use of medicines. The current study aims to explore the prescribers’ knowledge, perceptions and willingness to prescribe generic medicines in Hospital Seberang Jaya Penang State, Malaysia. A cross-sectional survey was conducted using a 23-item questionnaire among physicians practicing at Hospital Seberang Jaya, Malaysia. Data were analyzed using Statistical Package for Social Science (SPSS®) version 16. The majority of the respondents 121 (68.4%) were from the age group less than 30 years. Overall, only 7 (4.0%) were aware of the correct National Pharmaceutical Control Bureau’s bioequivalence range that was 80–125%. About 81 (45.8%) of the respondents were unaware of the safety of the generic medicines. Nearly one-third, 57 (32.2%), of the respondents had doubts about the efficacy of generic medicines. Most of the prescribers, 159 (89.8%), insisted on the need for the availability of guidelines or a protocol on brand substitution. The majority 152 (85.9%) believed that collaboration between pharmacist and physicians will be an option to promote the quality use of medicines. In physicians’ personal perspectives, 81 (45.7%) disclosed that it is simpler for them to remember the brand names and 93 (52.5%) stated that advertisements/marketing by the drug companies will influence their prescription pattern. Malaysian medical graduates were found to have poor knowledge about quality; safety and efficacy of generic medicines were common barriers to generic prescription. Marketing and promotional activities by the pharmaceutical companies will be the potential factors that may affect the prescription practices of the physicians.

Keywords

Physician perceptions generic medicines

Get full access to this article

View all access options for this article.

References

World Health Organization. The world medicines situation. Geneva, 2004.

Smith

Carlos Correa Cecilia

. Trade, trips, and pharmaceuticals. Lancet 2009; 373: 684–691.

Cameron

AEM

Ross-Degnan

Ball

. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 2009; 373: 240–249.

King

Kanavos

. Encouraging the use of generic medicines: implications for transition economies. Public Health 2002; 43: 462–469.

Cyrill de Run

. Patented and generic pharmaceutical drugs: perception and prescription. Int J Business Soc 2006; 7: 55–78.

Ping

Bahari

Hassali

. A pilot study on generic medicine substitution practices among community pharmacists in the State of Penang, Malaysia. Pharmacoepidemiol Drug Safety 2008; 17: 82–89.

Kesselheim

Misono

Lee

. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease. JAMA 2008; 300: 2514–2526.

Shrank

Cox

Fischer

. Patient perceptions of generic medications. Health Aff 2009; 28: 546–556.

Hassali

Kong

Stewart

. Generic medicines: perceptions of consumers in Melbourne, Australia. Int J Pharm Pract 2005; 13: 257–264.

10.

Hassali

Shafie

Jamshed

. Consumer’s view on generic medicines: a review of literature. Int J Pharm Pract 2009; 17: 79–88.

11.

Gedadi

Hassali

Shafie

. A pilot survey on perceptions and knowledge of generic medicines among consumers in Penang, Malaysia. Pharm Pract 2008; 6: 93–97.

12.

Chuaa

Hassali

Shafieb

. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia. Health Policy 2010; 95: 229–235.

13.

Parsons

Warnecke

Czaja

. Factors associated with response rates in a national survey of primary care physicians. Evaluation Rev 1994; 18: 756–756.

14.

Hassali

Kong

DCM

Stewart

. A comparison between senior medical students’ and pharmacy pre-registrants’ knowledge and perceptions of generic medicines. Med Educ 2007; 41: 703–710.

15.

Hassali

Kong

DCM

Stewart

. Generic medicine: perceptions of general practitioners in Melbourne, Australia. J Generic Med 2006; 3: 224–225.

16.

Sharrad

Hassali

Shafie

. Generic medicines: perceptions of physicians in Basrah, Iraq. Austr Med J 2009; 1: 58–64.

17.

King

Kanavos

. Encouraging the use of generic medicines: implications for transition economies. Croatian Med J 2002; 43: 462–469.

18.

Banahan

Kolassa

. A physician survey on generic drugs and substitution of critical dose medications. Arch Int Med 1997; 157: 2080–2088.

19.

McGettigan

McManus

O’Shea

. Low rate of generic prescribing in the Republic of Ireland compared to England and Northern Ireland: prescribers’ concerns. Irish Med J 1997; 90: 146–146.

20.

Sipkoff

. Getting serious about generics. Managed Care 2003; 12: 36–39.

21.

Ganther

Kreling

. Consumer perceptions of risk and required cost savings for generic prescription drugs. J Am Pharm Assoc 2000; 40: 378–383.

22.

Sanborn

White

. Pharmacists' perceptions and practices regarding the purchase of multisource pharmaceuticals. Hospital Pharm 1993; 28: 104–106, 109–113.

23.

Thomas

Vitrey

. Consumers' perception of generic medicines in community pharmacies in Malaysia. Southern Med Rev 2009; 2: 20–23.

24.

Alghasham

. Generic drug prescribing in central Saudi Arabia: perceptions and attitudes of physicians. Ann Saudi Med 2009; 29: 24–29.

25.

Meadows

. Greater access to generic drugs: new FDA initiatives to improve drug reviews and reduce legal Loopholes. FDA Consumer 2003; 37: 12–18.

26.

Medicines and Healthcare Products Regulatory Agency. Guidance note no. 25: best practice guidance on labelling and packaging of medicines. London, 2003.

27.

Lexchin

. Interactions between physicians and the pharmaceutical industry: what does the literature say? Can Med Assoc J 1993; 149: 1401–1401.

28.

Wazana

. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 2000; 283: 373–380.